Enanta Pharmaceuticals (ENTA) Free Cash Flow (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Free Cash Flow of -$7.2 million for Q1 2026, up 55.25% year-on-year from -$4.6 million in Q1 2025, and up 39.44% on a QoQ basis from -$11.8 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Free Cash Flow data on file, last reported at -$7.2 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 55.25% year-over-year to -$7.2 million; the trailing twelve-month figure through Mar 2026 stood at -$9.6 million (up 88.32% YoY), and the FY2025 full-year result was -$32.2 million, up 66.74% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$7.2 million, up from -$11.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $27.4 million in Q2 2025 and bottomed at -$38.8 million in Q4 2022.
- The 5-year median for Free Cash Flow is -$21.9 million (2024), against an average of -$19.6 million.
- The widest annual swing landed in 2022, when Free Cash Flow slumped 468.4%; it then jumped 246.21% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$38.8 million in 2022, then jumped by 33.56% to -$25.8 million in 2023, then rose by 0.89% to -$25.5 million in 2024, then soared by 53.64% to -$11.8 million in 2025, then jumped by 39.44% to -$7.2 million in 2026.
- The last three Free Cash Flow figures came in at -$7.2 million (Q1 2026), -$11.8 million (Q4 2025), and -$18.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -7.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.17 Mn |
| Mar 31, 2026 | -7.17 Mn |
| Dec 31, 2025 | -11.84 Mn |
| Dec 31, 2025 | -11.84 Mn |
| Sep 30, 2025 | -17.99 Mn |
| Sep 30, 2025 | -17.99 Mn |
| Jun 30, 2025 | 27.39 Mn |
| Jun 30, 2025 | 27.39 Mn |
| Mar 31, 2025 | -16.03 Mn |
| Mar 31, 2025 | -16.03 Mn |
| Dec 31, 2024 | -25.55 Mn |
| Dec 31, 2024 | -25.55 Mn |
| Sep 30, 2024 | -21.93 Mn |
| Sep 30, 2024 | -21.93 Mn |
| Jun 30, 2024 | -18.74 Mn |
| Jun 30, 2024 | -18.74 Mn |
| Mar 31, 2024 | -30.27 Mn |
| Mar 31, 2024 | -30.27 Mn |
| Dec 31, 2023 | -25.78 Mn |
| Dec 31, 2023 | -25.78 Mn |
| Sep 30, 2023 | -22.97 Mn |
| Sep 30, 2023 | -22.97 Mn |
| Jun 30, 2023 | -34.28 Mn |
| Jun 30, 2023 | -34.28 Mn |
| Mar 31, 2023 | -16.17 Mn |
| Mar 31, 2023 | -16.17 Mn |
| Dec 31, 2022 | -38.80 Mn |
| Dec 31, 2022 | -38.80 Mn |
| Sep 30, 2022 | -16.06 Mn |
| Sep 30, 2022 | -16.06 Mn |
| Jun 30, 2022 | -29.85 Mn |
| Jun 30, 2022 | -29.85 Mn |
| Mar 31, 2022 | -26.77 Mn |
| Mar 31, 2022 | -26.77 Mn |
| Dec 31, 2021 | -13.32 Mn |
| Dec 31, 2021 | -13.32 Mn |
| Sep 30, 2021 | -21.76 Mn |
| Sep 30, 2021 | -21.76 Mn |
| Jun 30, 2021 | -29.20 Mn |
| Jun 30, 2021 | -29.20 Mn |
| Mar 31, 2021 | -4.71 Mn |
| Mar 31, 2021 | -4.71 Mn |
| Dec 31, 2020 | -15.08 Mn |
| Dec 31, 2020 | -15.08 Mn |
| Sep 30, 2020 | -15.35 Mn |
| Sep 30, 2020 | -15.35 Mn |
| Jun 30, 2020 | -4.68 Mn |
| Jun 30, 2020 | -4.68 Mn |
| Mar 31, 2020 | 15.05 Mn |
| Mar 31, 2020 | 15.05 Mn |
| Dec 31, 2019 | 11.88 Mn |
| Dec 31, 2019 | 11.88 Mn |
| Sep 30, 2019 | 8.25 Mn |
| Sep 30, 2019 | 8.25 Mn |
| Jun 30, 2019 | 303,000.00 |
| Jun 30, 2019 | 303,000.00 |
| Mar 31, 2019 | 28.50 Mn |
| Mar 31, 2019 | 28.50 Mn |
| Dec 31, 2018 | 28.95 Mn |
| Dec 31, 2018 | 28.95 Mn |
| Sep 30, 2018 | 28.30 Mn |
| Sep 30, 2018 | 28.30 Mn |
| Jun 30, 2018 | 5.24 Mn |
| Jun 30, 2018 | 5.24 Mn |
| Mar 31, 2018 | -8.72 Mn |
| Mar 31, 2018 | -8.72 Mn |
| Dec 31, 2017 | 4.30 Mn |
| Dec 31, 2017 | 4.30 Mn |
| Sep 30, 2017 | 57.07 Mn |
| Sep 30, 2017 | 57.07 Mn |
| Jun 30, 2017 | -5.54 Mn |
| Jun 30, 2017 | -5.54 Mn |
| Mar 31, 2017 | -3.58 Mn |
| Mar 31, 2017 | -3.58 Mn |
| Dec 31, 2016 | 2.19 Mn |
| Dec 31, 2016 | 2.19 Mn |
| Sep 30, 2016 | 1.56 Mn |
| Sep 30, 2016 | 1.56 Mn |
| Jun 30, 2016 | -2.73 Mn |
| Jun 30, 2016 | -2.73 Mn |
| Mar 31, 2016 | 8.54 Mn |
| Mar 31, 2016 | 8.54 Mn |
| Dec 31, 2015 | 27.80 Mn |
| Dec 31, 2015 | 27.80 Mn |
| Sep 30, 2015 | -3.96 Mn |
| Sep 30, 2015 | -3.96 Mn |
| Jun 30, 2015 | -14.60 Mn |
| Jun 30, 2015 | -14.60 Mn |
| Mar 31, 2015 | 98.76 Mn |
| Mar 31, 2015 | 98.76 Mn |
| Dec 31, 2014 | -5.87 Mn |
| Dec 31, 2014 | -5.87 Mn |
| Sep 30, 2014 | -5.42 Mn |
| Sep 30, 2014 | -5.42 Mn |
| Jun 30, 2014 | 34.73 Mn |
| Jun 30, 2014 | 34.73 Mn |
| Mar 31, 2014 | -4.27 Mn |
| Mar 31, 2014 | -4.27 Mn |
| Dec 31, 2013 | -5.90 Mn |
| Dec 31, 2013 | -5.90 Mn |
| Sep 30, 2013 | -2.71 Mn |
| Sep 30, 2013 | -2.71 Mn |
| Jun 30, 2013 | -5.97 Mn |
| Jun 30, 2013 | -5.97 Mn |
| Mar 31, 2013 | 9.69 Mn |
| Mar 31, 2013 | 9.69 Mn |
| Dec 31, 2012 | 9.03 Mn |
| Dec 31, 2012 | 9.03 Mn |
| Sep 30, 2012 | -1.81 Mn |
| Sep 30, 2012 | -1.81 Mn |
| Jun 30, 2012 | -3.88 Mn |
| Jun 30, 2012 | -3.88 Mn |